30/09/2024.
This is the sixth blog in a series about a workshop on social and ethical issues and explainable artificial intelligence (xAI) recently hosted by the iToBoS project.
30/09/2024.
This is the sixth blog in a series about a workshop on social and ethical issues and explainable artificial intelligence (xAI) recently hosted by the iToBoS project.
24/09/2024.
The iToBoS 8th General Assembly (GA) and 7th Project Management Board (PMB) meetings took place on September 24th, 2024 in Budapest.
20/09/2024.
This is the fifth blog in a series about a recent workshop organised by the iToBoS project on explainable artificial intelligence (xAI) and social and ethical issues related to AI.
16/09/2024.
This is the fourth in a series of blogs about a recent workshop coordinated by the iToBoS project focused on explainable artificial intelligence (xAI) and ethical and social issues related to AI.
12/09/2024.
Digital technologies are making their mark in medicine, and especially also in art therapy, offering innovative therapeutic interventions for patients, including those with melanoma skin cancer.
9/09/2024.
This is the third blog in a series about a workshop hosted by the iToBoS project, focused on ethical and social issues related to artificial intelligence (AI) and key considerations about explainable AI (xAI) approaches.
4/09/2024.
This is the second blog in a series about a recent workshop conducted by iToBoS partners on ethical and social issues related to artificial intelligence (AI), as well as key considerations related to explainable AI (xAI).
29/08/2024.
The technical benefits of Artificial Intelligence (AI), such as early diagnosis of diseases and the positive outcomes that result from this, are well known.
23/08/2024.
As Artificial Intelligence (AI) continues to develop, significant advances are being made in its implementation in various fields to maximize its benefits, including healthcare.
21/08/2024.
The second Periodic Reporting, corresponding to the period M19-M36, was submitted to the EC on May 28th, 2024 (M38) and it was officially approved on August 20th, 2024.